These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients. Kulemann V; Bauer M; Graninger W; Joukhadar C Pharmacology; 2005 Dec; 75(4):165-78. PubMed ID: 16192747 [TBL] [Abstract][Full Text] [Related]
25. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects]. Schäfer-Korting M Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850 [TBL] [Abstract][Full Text] [Related]
26. The role of caspofungin and the echinocandins in the antifungal armamentarium. Morrison VA Curr Opin Investig Drugs; 2002 Oct; 3(10):1432-6. PubMed ID: 12431014 [TBL] [Abstract][Full Text] [Related]
27. Experiences with the use of caspofungin in paediatric patients. Lehrnbecher T; Groll AH Mycoses; 2008; 51 Suppl 1():58-64. PubMed ID: 18471162 [TBL] [Abstract][Full Text] [Related]
28. The use of caspofungin in HIV-infected individuals. Waters L; Nelson M Expert Opin Investig Drugs; 2007 Jun; 16(6):899-908. PubMed ID: 17501701 [TBL] [Abstract][Full Text] [Related]
29. A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK. Bruynesteyn K; Gant V; McKenzie C; Pagliuca T; Poynton C; Kumar RN; Jansen JP Eur J Haematol; 2007 Jun; 78(6):532-9. PubMed ID: 17419744 [TBL] [Abstract][Full Text] [Related]
30. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300 [TBL] [Abstract][Full Text] [Related]
31. Anidulafungin: a new echinocandin for the treatment of fungal infections. Cohen-Wolkowiez M; Benjamin DK; Steinbach WJ; Smith PB Drugs Today (Barc); 2006 Aug; 42(8):533-44. PubMed ID: 16969430 [TBL] [Abstract][Full Text] [Related]
33. Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients. Glasmacher A; Cornely OA; Orlopp K; Reuter S; Blaschke S; Eichel M; Silling G; Simons B; Egerer G; Siemann M; Florek M; Schnitzler R; Ebeling P; Ritter J; Reinel H; Schütt P; Fischer H; Hahn C; Just-Nuebling G J Antimicrob Chemother; 2006 Jan; 57(1):127-34. PubMed ID: 16308418 [TBL] [Abstract][Full Text] [Related]
34. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia. Makowsky MJ; Warkentin DI; Savoie ML Ann Pharmacother; 2005; 39(7-8):1365-6. PubMed ID: 15956243 [No Abstract] [Full Text] [Related]
35. Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections. Sanz-Rodriguez C; Lopez-Duarte M; Jurado M; Lopez J; Arranz R; Cisneros JM; Martino ML; Garcia-Sanchez PJ; Morales P; Olivé T; Rovira M; Solano C Bone Marrow Transplant; 2004 Jul; 34(1):13-20. PubMed ID: 15122312 [TBL] [Abstract][Full Text] [Related]
36. Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation. Pancham S; Hemmaway C; New H; Albert E; Dokal I; Roberts IA; McCloy M Pediatr Transplant; 2005 Apr; 9(2):254-7. PubMed ID: 15787803 [TBL] [Abstract][Full Text] [Related]
37. Use of newer antifungal therapies in clinical practice: what do the data tell us? Perfect JR Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178 [TBL] [Abstract][Full Text] [Related]
38. Micafungin (Mycamine) for fungal infections. Med Lett Drugs Ther; 2005 Jun; 47(1211):51-2. PubMed ID: 15961968 [TBL] [Abstract][Full Text] [Related]
39. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections. Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298 [TBL] [Abstract][Full Text] [Related]